1 | K(D)PT | - | - | - | - | 1件: 97 97 |
2 | K-832 | - | - | - | - | 1件: 46 46 |
3 | K0706 | - | - | - | - | 1件: 6 6 |
4 | Kaftrio | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
5 | Kaletra | 1件: Lopinavir Lopinavir | 1件: D01425
D01425
| - | - | 1件: 93 93 |
6 | Kaletra (lopinavir [LPVr]) | 1件: Lopinavir Lopinavir | 1件: D01425
D01425
| - | - | 1件: 265 265 |
7 | Kalydeco | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
8 | Kalydeco 150 mg film-c | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
9 | Kalydeco 150 mg film-coated tablets | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
10 | Kalydeco 150mg | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
11 | Kamada -AAT for Inhalation or inhaled AAT (AAT) | - | - | - | - | 1件: 231 231 |
12 | Kamada-AAT for inhalation | - | - | - | - | 1件: 231 231 |
13 | Kamada-AAT for Inhalation, 160mg | - | - | - | - | 1件: 231 231 |
14 | Kamada-AAT for Inhalation, 80mg | - | - | - | - | 1件: 231 231 |
15 | Kamada-API | - | - | - | - | 1件: 231 231 |
16 | Kamillenblüten 3ml/10ml | - | - | - | - | 1件: 97 97 |
17 | Kanamycin | 1件: Kanamycin Kanamycin | 3件: D00866
D00866
,
D03262
,
D07497
| - | - | 2件: 96 96, 291 |
18 | KANUMA | 1件: Sebelipase alfa Sebelipase alfa | 1件: D10377
D10377
| 1件: LIPA LIPA 💬 | 3件: Cholesterol metabolism Cholesterol metabolism, Lysosome, Steroid biosynthesis 💬 | 1件: 19 19 |
19 | Kappa (light chain) | - | - | - | - | 1件: 61 61 |
20 | Kappaproct | - | - | - | - | 1件: 97 97 |
21 | KAR5585 Capsules | - | - | - | - | 1件: 86 86 |
22 | KB001 | 1件: KB001 KB001 | - | - | - | 1件: 299 299 |
23 | KB001-A | 1件: KB001 KB001 | - | - | - | 1件: 299 299 |
24 | KB003 | - | - | - | - | 1件: 46 46 |
25 | KB105 | - | - | - | - | 1件: 160 160 |
26 | KB195 | - | - | - | - | 1件: 251 251 |
27 | KBL697 | - | - | - | - | 1件: 97 97 |
28 | KC706 | 1件: KC706 KC706 | - | - | - | 2件: 35 35, 46 |
29 | KCT-0809 ophthalmic solution | - | - | - | - | 1件: 53 53 |
30 | KD019 (tesevatinib) | 1件: Tesevatinib Tesevatinib | 1件: D11772
D11772
| 5件: EGFR EGFR, EPHB4, ERBB2, FLT4, KDR 💬 | 53件: Adherens junction Adherens junction, Axon guidance, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease - COVID-19, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Platinum drug resistance, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Tight junction, VEGF signaling pathway 💬 | 1件: 67 67 |
31 | KD025 | - | - | - | - | 1件: 85 85 |
32 | KdPT | - | - | - | - | 1件: 97 97 |
33 | KDT-3594 | - | - | - | - | 1件: 6 6 |
34 | Kedrion IVIG 10% | - | - | - | - | 1件: 65 65 |
35 | Kemstro | - | - | - | - | 1件: 13 13 |
36 | Kenacort | - | - | - | - | 2件: 46 46, 96 |
37 | Kenalog | 1件: Triamcinolone Triamcinolone | 5件: D00385
D00385
,
D00983
,
D00984
,
D00985
,
D06216
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 |
38 | Kenalog Injectable Product | - | - | - | - | 1件: 70 70 |
39 | Kepivance | 1件: Palifermin Palifermin | 1件: D05338
D05338
| 1件: FGFR2 FGFR2 💬 | 13件: Calcium signaling pathway Calcium signaling pathway, Central carbon metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Gastric cancer, MAPK signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells 💬 | 1件: 13 13 |
40 | KEPPRA | 1件: Levetiracetam Levetiracetam | 1件: D00709
D00709
| 1件: SV2A SV2A 💬 | 1件: ECM-receptor interaction ECM-receptor interaction 💬 | 1件: 13 13 |
41 | Keppra 250mg | 1件: Levetiracetam Levetiracetam | 1件: D00709
D00709
| 1件: SV2A SV2A 💬 | 1件: ECM-receptor interaction ECM-receptor interaction 💬 | 1件: 13 13 |
42 | Keppra 500mg | 1件: Levetiracetam Levetiracetam | 1件: D00709
D00709
| 1件: SV2A SV2A 💬 | 1件: ECM-receptor interaction ECM-receptor interaction 💬 | 1件: 13 13 |
43 | Keppra ® | 1件: Levetiracetam Levetiracetam | 1件: D00709
D00709
| 1件: SV2A SV2A 💬 | 1件: ECM-receptor interaction ECM-receptor interaction 💬 | 1件: 13 13 |
44 | Kera-X | - | - | - | - | 1件: 168 168 |
45 | Kesimpta | 1件: Ofatumumab Ofatumumab | 1件: D09314
D09314
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 |
46 | Kesimpta 20 mg Injektionslösung im Fertigpen | 1件: Ofatumumab Ofatumumab | 1件: D09314
D09314
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 |
47 | Kesimpta 20 mg solution for injection in pre-filled pen | 1件: Ofatumumab Ofatumumab | 1件: D09314
D09314
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 |
48 | KETAMINE | 1件: Ketamine Ketamine | 2件: D00711
D00711
,
D08098
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 6件: 6 6, 13, 70, 113, 156, 215 |
49 | Ketamine Infusion | 1件: Ketamine Ketamine | 2件: D00711
D00711
,
D08098
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 6 6 |
50 | Ketanest | - | - | - | - | 3件: 2 2, 4, 70 |
51 | Ketanest-S | - | - | - | - | 3件: 2 2, 4, 70 |
52 | KetoCal | - | - | - | - | 1件: 2 2 |
53 | Ketocal 4:1 liquid Nutricia (intervention) | - | - | - | - | 1件: 256 256 |
54 | Ketoconazole | 1件: Ketoconazole Ketoconazole | 1件: D00351
D00351
| 1件: CYP17A1 CYP17A1 💬 | 6件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Ovarian steroidogenesis, Prolactin signaling pathway, Steroid hormone biosynthesis 💬 | 3件: 8 8, 13, 75 |
55 | Ketoflo | - | - | - | - | 1件: 248 248 |
56 | Ketogenic diet | - | - | - | - | 2件: 145 145, 230 |
57 | Ketone ester drink | - | - | - | - | 1件: 6 6 |
58 | Ketone Ester Elite endurance Nutrition Drink | - | - | - | - | 1件: 6 6 |
59 | Ketone Monoester | - | - | - | - | 1件: 299 299 |
60 | Ketoprofen | 1件: Ketoprofen Ketoprofen | 1件: D00132
D00132
| 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 |
61 | Ketorolac | 1件: Ketorolac Ketorolac | 2件: D00813
D00813
,
D08104
| 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 2件: 70 70, 226 |
62 | Ketorolac Tromethamine | 2件: Ketorolac Ketorolac, Tromethamine | 3件: D00396
D00396
,
D00813
,
D08104
| 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 226 226 |
63 | Kevzara | 1件: Sarilumab Sarilumab | 1件: D10161
D10161
| 1件: IL6R IL6R 💬 | 12件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 2件: 41 41, 46 |
64 | Kevzara ® | 1件: Sarilumab Sarilumab | 1件: D10161
D10161
| 1件: IL6R IL6R 💬 | 12件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 41 41 |
65 | Keyhole limpet hemocyanin | 1件: Keyhole limpet hemocyanin Keyhole limpet hemocyanin | - | - | - | 2件: 13 13, 46 |
66 | Keyhole limpet hemocyanin (KLH) | 1件: Keyhole limpet hemocyanin Keyhole limpet hemocyanin | - | - | - | 1件: 13 13 |
67 | Keyhole limpet hemocyanin (KLH) neo-antigen | 1件: Keyhole limpet hemocyanin Keyhole limpet hemocyanin | - | - | - | 1件: 13 13 |
68 | Keyo | - | - | - | - | 1件: 248 248 |
69 | KH176 | - | - | - | - | 1件: 21 21 |
70 | KHK4083 | - | - | - | - | 1件: 97 97 |
71 | KHK4827 | - | - | - | - | 2件: 37 37, 51 |
72 | KHK4827 140mg SC | - | - | - | - | 1件: 37 37 |
73 | KHK4827 210mg SC | - | - | - | - | 1件: 37 37 |
74 | KIg10 | - | - | - | - | 1件: 65 65 |
75 | KIN-1901 | - | - | - | - | 1件: 271 271 |
76 | Kineret | 1件: Anakinra Anakinra | 1件: D02934
D02934
| 2件: IL1R1 IL1R1, IL1R2 💬 | 15件: Amoebiasis Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | 9件: 28 28, 41, 46, 49, 65, 106, 107, 266, 299 |
77 | KINERET*SC 7SIR 100MG 0,67ML | 1件: Anakinra Anakinra | 1件: D02934
D02934
| 2件: IL1R1 IL1R1, IL1R2 💬 | 15件: Amoebiasis Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | 3件: 28 28, 46, 107 |
78 | Kineret® | 1件: Anakinra Anakinra | 1件: D02934
D02934
| 2件: IL1R1 IL1R1, IL1R2 💬 | 15件: Amoebiasis Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | 1件: 46 46 |
79 | Kineret® (Anakinra) | 1件: Anakinra Anakinra | 1件: D02934
D02934
| 2件: IL1R1 IL1R1, IL1R2 💬 | 15件: Amoebiasis Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | 1件: 46 46 |
80 | Kineret® or anakinra | 1件: Anakinra Anakinra | 1件: D02934
D02934
| 2件: IL1R1 IL1R1, IL1R2 💬 | 15件: Amoebiasis Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | 1件: 107 107 |
81 | Kinetra and Soletra (neurostimulator, Medtronic) | - | - | - | - | 1件: 6 6 |
82 | Kinoquinone (proposed) | - | - | - | - | 1件: 6 6 |
83 | KIO-301 | - | - | - | - | 1件: 90 90 |
84 | KIOVIG | 1件: Human immunoglobulin G Human immunoglobulin G | - | - | - | 2件: 14 14, 65 |
85 | KIOVIG 100 mg/ml solution for infusion | 1件: Human immunoglobulin G Human immunoglobulin G | - | - | - | 2件: 14 14, 65 |
86 | Kirunal Fish Oil | 1件: Fish oil Fish oil | - | - | - | 1件: 13 13 |
87 | KJX839 | - | - | - | - | 1件: 79 79 |
88 | KL1333 | - | - | - | - | 1件: 21 21 |
89 | Klacid | - | - | - | - | 1件: 299 299 |
90 | KLH | - | - | - | - | 2件: 13 13, 65 |
91 | KM-819 | - | - | - | - | 1件: 6 6 |
92 | KN019, 10 mg/kg | - | - | - | - | 1件: 46 46 |
93 | KN019, 5mg/kg | - | - | - | - | 1件: 46 46 |
94 | KNS-760704 | - | - | - | - | 1件: 2 2 |
95 | Kolbet | - | - | - | - | 1件: 46 46 |
96 | Korean Red Ginseng | 1件: Ginseng Ginseng | 1件: D06772
D06772
| - | - | 1件: 53 53 |
97 | Koselugo | 1件: Selumetinib Selumetinib | 1件: D09666
D09666
| 2件: MAP2K1 MAP2K1, MAP2K2 💬 | 89件: Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | 1件: 34 34 |
98 | Koselugo 10mg | 1件: Selumetinib Selumetinib | 1件: D09666
D09666
| 2件: MAP2K1 MAP2K1, MAP2K2 💬 | 89件: Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | 1件: 34 34 |
99 | Koselugo 25mg | 1件: Selumetinib Selumetinib | 1件: D09666
D09666
| 2件: MAP2K1 MAP2K1, MAP2K2 💬 | 89件: Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | 1件: 34 34 |
100 | KPG-818 | - | - | - | - | 1件: 49 49 |
101 | KPL-301 | - | - | - | - | 1件: 41 41 |
102 | KPS-0373 | - | - | - | - | 1件: 18 18 |
103 | KPS-0373, High dose | - | - | - | - | 1件: 18 18 |
104 | KPS-0373, Low dose | - | - | - | - | 1件: 18 18 |
105 | KR002524 | - | - | - | - | 1件: 46 46 |
106 | Kremezin | - | - | - | - | 2件: 96 96, 97 |
107 | Kremezin®, Spherical Adsorptive Carbon | 1件: Activated charcoal Activated charcoal | - | - | - | 2件: 96 96, 97 |
108 | Kreon 25 000 | - | - | - | - | 1件: 299 299 |
109 | Kreon 25,000 Units | - | - | - | - | 1件: 299 299 |
110 | Kreon 25000 | - | - | - | - | 2件: 298 298, 299 |
111 | KREON de Liberación Inmediata | - | - | - | - | 1件: 299 299 |
112 | KREON N 25000 | - | - | - | - | 1件: 299 299 |
113 | Kreon® 25,000 | - | - | - | - | 1件: 299 299 |
114 | Krio | - | - | - | - | 1件: 248 248 |
115 | KRN23 | - | - | - | - | 1件: 238 238 |
116 | KRP-116D | - | - | - | - | 1件: 226 226 |
117 | KRP203 | - | - | - | - | 1件: 97 97 |
118 | KRP203A | - | - | - | - | 1件: 97 97 |
119 | Kunxian Capsule | - | - | - | - | 2件: 46 46, 271 |
120 | KUVAN | 1件: Sapropterin Sapropterin | 1件: D08505
D08505
| - | - | 1件: 240 240 |
121 | Kuvan 100mg soluble tablet | 1件: Sapropterin Sapropterin | 1件: D08505
D08505
| - | - | 1件: 240 240 |
122 | KuvanTM Therapy | - | - | - | - | 1件: 240 240 |
123 | Kuvan® | 1件: Sapropterin Sapropterin | 1件: D08505
D08505
| - | - | 1件: 240 240 |
124 | Kuvan® (sapropterin dihydrochloride) | 1件: Sapropterin Sapropterin | 1件: D08505
D08505
| - | - | 1件: 240 240 |
125 | KVD824 | - | - | - | - | 1件: 65 65 |
126 | KVD824 300 mg Compresse a rilascio modificato | - | - | - | - | 1件: 65 65 |
127 | KVD824 300 mg Modified Release Tablets | 1件: Manganese citrate Manganese citrate | - | - | - | 1件: 65 65 |
128 | KVD824 hydrochloride | - | - | - | - | 1件: 65 65 |
129 | KVD900 | - | - | - | - | 1件: 65 65 |
130 | KVD900 100 mg Film Coated Tablet | - | - | - | - | 1件: 65 65 |
131 | KVD900 300 mg | - | - | - | - | 1件: 65 65 |
132 | KVD900 600 mg | - | - | - | - | 1件: 65 65 |
133 | KW-0761 | - | - | - | - | 1件: 26 26 |
134 | KW-0761 0.3 mg/kg IV | - | - | - | - | 1件: 26 26 |
135 | KW-6002 | - | - | - | - | 1件: 6 6 |
136 | KW-6002 (istradefylline) | 1件: Istradefylline Istradefylline | 1件: D04641
D04641
| 1件: ADORA2A ADORA2A 💬 | 7件: Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | 1件: 6 6 |
137 | KW-6356 | - | - | - | - | 1件: 6 6 |
138 | KW-6356 High Dose | - | - | - | - | 1件: 6 6 |
139 | KW-6356 Low Dose | - | - | - | - | 1件: 6 6 |
140 | KW-6356 Middle Dose | - | - | - | - | 1件: 6 6 |
141 | KW-6356 X Dose | - | - | - | - | 1件: 6 6 |
142 | KW-6356 Y Dose | - | - | - | - | 1件: 6 6 |
143 | KW-6500 | - | - | - | - | 1件: 6 6 |
144 | Kybella | 1件: Deoxycholic acid Deoxycholic acid | 1件: D10781
D10781
| - | - | 1件: 34 34 |
145 | Kyo-Dophilus | - | - | - | - | 1件: 97 97 |
146 | KZR-616 | 1件: KZR-616 KZR-616 | - | - | - | 3件: 49 49, 50, 61 |
147 | KZR-616 maleate | 1件: KZR-616 KZR-616 | - | - | - | 1件: 50 50 |
148 | Kümmel 2ml/10ml | - | - | - | - | 1件: 97 97 |